GL1X · GenesisL1 explorer

Research workbench

C-terminal cysteine-rich domain of human chfr bound to P(1), P(2)-diadenosine-5'-pyrophosphate

Analyse C-terminal cysteine-rich domain of human chfr bound to P(1)… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2XOY
Type
protein
Length
426 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
E3 ubiquitin-protein ligase chfr
EC
6.3.2.-
UniProt
Q96EP1
Ligands
AMP, ADE, ZN
Pockets
1 · best druggability 0.60

Structure

x-ray diffraction · 2 distinct chains · 37% helix, 7% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AE3 ubiquitin-protein ligase chfr (EC 6.3.2.-)protein21239% helix, 8% strandQ96EP1
BE3 ubiquitin-protein ligase chfr (EC 6.3.2.-)protein21436% helix, 7% strandQ96EP1

Ligands and binding sites

  • AMP · Adenosine monophosphate · ligand · chains B
  • ADE · Adenine · ligand · chains B
  • ZN · Zinc ion · metal · 10 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12080.600.8124empty

Interfaces

1 interface between chains.

  • A–B · 449 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 2XOY · C-terminal cysteine-rich domain of human CHFR bound to P(1),P(2)… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q96EP1 · AlphaFold monomer V2.0 prediction for E3 ubiquitin-protein ligase chfr (Q96EP1) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.